Crescent Capital BDC (NASDAQ:CCAP) Reaches New 52-Week Low – Time to Sell?

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) reached a new 52-week low during mid-day trading on Monday . The stock traded as low as $16.64 and last traded at $17.12, with a volume of 168825 shares changing hands. The stock had previously closed at $17.10.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company lowered their price target on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Friday, February 21st. One analyst has rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $19.20.

Read Our Latest Analysis on CCAP

Crescent Capital BDC Price Performance

The firm has a market capitalization of $632.28 million, a PE ratio of 8.57 and a beta of 0.82. The firm’s fifty day moving average price is $18.50 and its 200 day moving average price is $18.78. The company has a current ratio of 1.32, a quick ratio of 1.26 and a debt-to-equity ratio of 1.18.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.55 EPS for the quarter, missing the consensus estimate of $0.56 by ($0.01). The business had revenue of $46.40 million during the quarter, compared to analysts’ expectations of $47.27 million. Crescent Capital BDC had a net margin of 37.32% and a return on equity of 11.90%. As a group, equities analysts forecast that Crescent Capital BDC, Inc. will post 2.09 earnings per share for the current year.

Crescent Capital BDC Announces Dividend

The business also recently announced a dividend, which was paid on Friday, March 14th. Investors of record on Friday, February 28th were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, February 28th. Crescent Capital BDC’s dividend payout ratio (DPR) is 84.42%.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of CCAP. Montag A & Associates Inc. acquired a new stake in shares of Crescent Capital BDC during the 4th quarter worth approximately $35,000. C M Bidwell & Associates Ltd. purchased a new stake in Crescent Capital BDC during the fourth quarter worth $39,000. Aquatic Capital Management LLC acquired a new stake in Crescent Capital BDC during the fourth quarter valued at $129,000. Generation Capital Management LLC purchased a new position in Crescent Capital BDC in the fourth quarter valued at $192,000. Finally, Dynamic Technology Lab Private Ltd acquired a new position in shares of Crescent Capital BDC in the fourth quarter worth about $218,000. 49.46% of the stock is owned by institutional investors and hedge funds.

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.